Taiwan Scientists Test Protein Enabling Colorectal, Cervical Cancers
This article was originally published in PharmAsia News
Tawainese researchers are testing an adaptor protein that causes cancer as a likely target for treating colorectal, cervical and possibly other cancers. The scientific team said the Eps8 protein had been linked to colorectal cancer two years ago, and then to cervical cancer, but now the researchers believe it enhances the proliferation of cells associated with the two cancers. By lowering the level of Eps8 in animals, the team achieved a decrease in tumor growth. (Click here for more
You may also be interested in...
US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
California proposes limiting short-form Prop 65 warnings to products with 5 inches or less of labeling space, while prohibiting their use in online and catalog warnings. The number of products with the warnings, used even on vacuum cleaners, luggage and guitars, has made tracking them impossible.